By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Trevena, Inc. 

Berwyn  Pennsylvania    U.S.A.
Phone: n/a Fax: n/a



Drug Discovery

Company News
Trevena, Inc. (TRVN) To Present At The 18th Annual BIO CEO & Investor Conference 2/4/2016 9:27:03 AM
Trevena, Inc. (TRVN) Announces Initiation Of Oliceridine Phase 3 Clinical Program With Multi-Procedure Safety And Tolerability Study 1/19/2016 10:41:03 AM
Trevena, Inc. (TRVN) Added To NASDAQ Biotechnology Index (NBI) 12/16/2015 11:21:25 AM
Trevena, Inc. (TRVN) Announces FDA Grant Of Fast Track Designation To Oliceridine (TRV130) For The Management Of Moderate-To-Severe Acute Pain 12/4/2015 11:13:39 AM
Trevena, Inc. (TRVN) Granted Key Composition Of Matter And Use Patent For TRV027 In Europe 12/3/2015 11:51:46 AM
Trevena, Inc. (TRVN) To Present At The Oppenheimer 26th Annual Healthcare Conference 12/3/2015 8:32:18 AM
Trevena, Inc. (TRVN) CEO To Present At The Jefferies and Co. 2015 Global Healthcare Conference 11/12/2015 11:38:59 AM
Trevena, Inc. (TRVN) Reports Third Quarter 2015 Financial Results And Provides Corporate Update 11/10/2015 11:21:42 AM
Trevena, Inc. (TRVN) Hosts Investor And Analyst Day 10/29/2015 11:10:00 AM
Trevena, Inc. (TRVN) To Host Analyst And Investor Day On October 28, 2015 10/21/2015 8:14:48 AM